Harvard Molecular Diagnostics Current Roles in Cancer Diagnosis 2026

Description

Include: 40 Videos (.mp4)+ 40 Subtitles (.vtt) + 41 PDFs, size: 5.47 GB

Target Audience: pathologists, oncologists, and laboratory directors

1. Overview

The Harvard Molecular Diagnostics: Current Roles in Cancer Diagnosis 2026 program provides a comprehensive exploration of the latest advancements and practical applications in molecular oncology. The course covers critical topics such as Next-Generation Sequencing (NGS) pipelines, bioinformatics, liquid biopsies, and tumor-specific molecular markers, empowering practitioners to enhance precision medicine and diagnostic accuracy in clinical settings.

Course Date: April 13, 2026 – April 15, 2026

2. Learning Objectives

• Explain the fundamental principles and methodologies of molecular diagnostics relevant to cancer care.
•  Interpret and apply molecular test results to guide diagnosis, prognosis, and therapeutic decision-making.
•  Communicate molecular test findings effectively within interdisciplinary care teams and with patients.
•  Evaluate the practical considerations of molecular testing, including test selection, cost, and access.
•  Integrate recent advances in molecular oncology into clinical practice to improve patient-centered outcomes.

3. Target Audience

Best for pathologists, oncologists, and laboratory directors who want updates on NGS, liquid biopsy, and advanced molecular cancer diagnostics.

4. Topics

1. 01 Integrated Molecular Oncology in 2026 Trends and Tools for Gene Fusion Detection

2. 02 End-to-end Process to Accelerating Treatment Initiation with Next-day NGS

3. 03 Translation of Molecular to Immunohistochemistry

4. 04 Informatics Architecture

5. 05 NGS Pipelines Demystified Practical Bioinformatics

6. 06 Tumor Mutation Burden, MSI, and HRD

7. 07 Indel Detection

8. 08 Viral Sequence Detection and Other Signatures

9. 09 Gene Fusion Detection and Interpretation by RNA-based NGS a Practical, Cased-based Approach

10. 10 Additional Informatics Analyses Detection of Clinically Significant Isoforms and Sub-gene Events through RNA andor DNA-based NGS

11. 11 Oncogenicity Interpretation of Gene Fusions Detected by RNA-based NGS

12. 12 Applications of Long-Read Sequencing for Cancer Diagnostics

13. 13 Liquid Biopsy and ctDNA Technical and Clinical Perspectives

14. 14 Panel Discussion Tissue vs Liquid Biopsy

15. 15 Sarcoma and Fusion Testing

16. 16 Molecular Diagnostics for GYN Tumors

17. 17 Molecular Diagnostics for Pediatric Tumors

18. 18 GU Cancers Molecular Markers (Only PDF, No Video)

19. 19 Copy Number Variation via NGS and Microarray

20. 20 Cytogenomics Technical Focus

21. 21 Cytogenomics Clinical Focus

22. 22 Gliomas and Methylation Profiling

23. 23 Germline Testing in Oncology What, When, and How

24. 24 Tumor-Normal Paired Sequencing Clinical Impact

25. 25 Case Review Pathology Oncology Perspectives

26. 26 Melanoma Molecular Pathology

27. 27 Molecular Diagnostics for Breast Cancer

28. 28 Tumor Board Simulation Real Case Review

29. 29 Myeloid Neoplasms and MRD Testing

30. 30 Leukemia Molecular Diagnostics (B- and T-cell)

31. 31 Molecular Diagnostics and Lymphoma

32. 32 Pharmacogenomics in Oncology Management

33. 33 Lung Tumor Testing

    34. GI Cancer Case-Based Applications VIDEO + PDF Not Release

34. 35 Thyroid Cancer and Salivary Tumor Genomics

35. 36 AI in Molecular Oncology

36. 37 Interactive Workshop Case Report Writing and Communication

37. 38 The Power of Patient Partnership in Cancer Advocacy

38. 39 Building a Molecular Profiling Program

39. 40 Regulatory and Reimbursement Essentials

40. 41 Lab Leadership and Challenges

41. 42 Future Directions in Molecular Oncology